Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk

Journal of Genetic Counseling

Volumn 16, Issue 3, 2007, Pages 325-339

  Wakefield, Claire E ^a,b   Meiser, Bettina ^b,c   Homewood, Judi ^a   Peate, Michelle ^b   Kirk, Judy ^d   Warner, Beverley ^e   Lobb, Elizabeth ^f   Gaff, Clara ^g   Tucker, Kathy ^b,h  

^a MACQUARIE UNIVERSITY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

^e CABRINI HOSPITAL   (Australia)

^f EDITH COWAN UNIVERSITY   (Australia)

^g Genetic Health Services Victoria   (Australia)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Decision aids; Genetic testing; Hereditary breast cancer; HNPCC

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; COLORECTAL CANCER; DECISION SUPPORT SYSTEM; EMOTION; FAMILIAL CANCER; FEMALE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MEDICAL DECISION MAKING; OVARY CANCER; PATIENT ATTITUDE; PATIENT SATISFACTION; PILOT STUDY; RISK ASSESSMENT;

ADAPTATION, PSYCHOLOGICAL; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DECISION SUPPORT TECHNIQUES; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MALE; OVARIAN NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS;

EID: 34249950110     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-006-9068-x     Document Type: Article

References (70)

1. Aktan-Collan, K., Haukkala, A., Mecklin, J., Uutela, A., et al. (2001). Psychological consequences of predictive testing for hereditary non-polyposis colorectal cancer (HNPCC): A prospective follow up study. Int J Cancer, 93, 608-611.
2. Armstrong, K., Micco, E., Carney, A., Stopfer, J., et al. (2005). Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA, 293(14), 1729-1736.
3. Australian Bureau of Statistics (2006). Australian social trends 2006. Canberra, Australian Bureau of Statistics.
4. Ayme, S., Marquart-Moulin, G., Julian-Reymier, C., Chabal, F., et al. (1993). Diffusion of information about genetic risk within families. Neuromuscul Disord, 3, 571-574.
5. Bebbington Hatcher, M., Fallowfield, L., & A'Hern, R. (2001). The psychological impact of prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews. Br Med J, 322(322), 76-79.
6. Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., et al. (2003). Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet, Part A, 118(3), 201-209.
7. Braithwaite, D., Emery, J., Walter, F., Prevost, A. T., et al. (2006). Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Familial Cancer, 5(1), 61-75.
8. Brehaut, J. C., O'Connor, A. M., Wood, T. J., Hack, T. F., et al. (2003). Validation of a decision regret scale. Med Decis Making, 23(4), 281-292.
9. Broadstock, M., Michie, S., Gray, J., MacKay, J., et al. (2000). The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer - A pilot study. Psycho-Oncology, 9, 537-548.
10. Burke, W., & Lata, M. B. (1999). Genetic risk and breast cancer survival: Another link in the chain of evidence. J Natl Cancer Inst, 91(3), 201-203.
11. Butow, P., Brindle, E., McConnell, D., Boakes, R., et al. (1998). Information booklets about cancer: Factors influencing patient satisfaction and utilisation. Patient Educ Counsel, 33, 129-141.
12. Claes, E., Denayer, L., Evers-Kiebooms, G., Boogaerts, A., et al. (2004). Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Counsel, 55(2), 265-274.
13. Cull, A., Anderson, E. D. C., Campbell, S., Mackay, J., et al. (1999). The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. Br J Cancer, 79(3-4), 501-508.
14. Daly, M. B., Barsevick, A., Miller, S. M., Buckman, R., et al. (2001). Communicating genetic test results to the family: A six-step skills-building strategy. Fam Commun Health, 24(3), 13-26.
15. Ford, D., Easton, D. F., Stratton, M., Narod, S., et al. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Human Genet, 62(3), 676-689.
16. Fry, A., Busby-Earle, C., Rush, R., & Cull, A. (2001). Prophylactic oophorectomy versus screning: Psychosocial outcomes in women at increased risk of ovarian cancer. Psycho-Oncology, 10, 231-241.
17. Gaff, C., Collins, V., Symes, T., & Halliday, J. (2005). Facilitating family communication about predictive testing: Probands' perceptions. J Genet Counsel, 14(2), 133-140.
18. Glanz, K., Grove, J., Lerman, C., Gotay, C., et al. (1999). Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev, 8(4 II), 329-336.
19. Green, M. J., Peterson, S. K., Baker, M. W., Harper, G. R., et al. (2004). Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. J Am Med Assoc, 292(4), 442-452.
20. Hadley, D. W., Jenkins, J. F., Dimond, E., De Carvalho, M., et al. (2004). Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol., 22(1), 39-44.
21. Hallowell, N., MacKay, J., Richards, M., Gore, M., et al. (2004). High-risk women's experiences of undergoing prophylactic oophorectomy: A descriptive study. Genet Test, 8(2), 148-156.
22. Hopwood, P. (2005). Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer. Curr Opin Oncol, 17(4), 340-344.
23. Human Genetics Society of Australasia (1998). Guidelines for DNA predictive testing.
24. Kardia, S. L., & Wang, C. (2005). The role of health education and behavior in public health genetics. Health Educ Behav, 32(5), 583-588.
25. Lackner, C., & Hoefler, G. (2005). Critical issues in the identification and management of patients with hereditary non-polyposis colorectal cancer. Eur J Gastroenterol Hepatol, 17(3), 317-322.
26. Lerman, C., Biesecker, B., & Benkendorf, J. L. (1997). Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst, 89(2), 148-157.
27. Lerman, C., Lustbader, E., Rimer, B., Daly, M., et al. (1995). Effects of individualised breast cancer risk counseling: A randomized trial. J Natl Cancer Inst, 87(4), 286-301.
28. Lobb, E., Butow, P., Meiser, B., Barratt, A., et al. (2002). Tailoring communication in consultations with women from high-risk breast cancer families. Br J Cancer, 87(5), 502-508.
29. Lobb, E., Butow, P., Meiser, B., Tucker, K., et al. (2001). How do geneticists and genetic counselors counsel women from high-risk breast cancer families? J Genet Counsel, 10(2), 185-199.
30. Lobb, E., Butow, P., Moore, A., Barratt, A., et al. (2006). Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: A pilot study. J Genet Counsel, 15(5), 393-405.
31. Lodder, L., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., et al. (2001). Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet, 98, 15-24.
32. McAllister, M. F., Evans, D. G. R., Ormiston, W., & Daly, P. (1998). Men in breast cancer families: A preliminary qualitative study of awareness and experience. J Med Genet, 35, 739-744.
33. Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology, 14(12), 1060-1074.
34. Meiser, B., Collins, V., Warren, R., Gaff, C., et al. (2004). Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet, 66(6), 502-511.
35. Metcalfe, K. A., Esplen, M. J., Goel, V., & Narod, S. A. (2004). Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psycho-Oncology, 13(1), 14-25.
36. Michie, S., Dormandy, E., & Marteau, T. M. (2002). The multi-dimensional measure of informed choice: A validation study. Patient Educ Counsel, 48(1), 87-91.
37. Miller, S. M., Diefenbach, M. A., Kruus, L. K., Watkins-Bruner, D., et al. (2001). Psychological and Screening Profiles of First-Degree Relatives of Prostate Cancer Patients. J Behav Med, 24(3), 247-258.
38. Miller, S. M., Fang, C. Y., Manne, S. L., Engstrom, P. F., et al. (1999). Decision making about prophylactic oophorectomy among at-risk women: Psychological influences and implications. Gynecol Oncol, 75, 406-412.
39. Miller, S. M., Fleisher, L., Roussi, P., Buzaglo, J. S., et al. (2005a). Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service. J Health Commun, 1, 119-136.
40. Miller, S. M., Roussi, P., Daly, M. B., Buzaglo, J. S., et al. (2005b). Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors. Health Edu Behav, 32(5), 654-667.
41. Montgomery, G. H., Erblich, J., DiLorenzo, T., & Bovbjerg, D. H. (2003). Family and friends with disease: Their impact on perceived risk. Prev Med, 37(3), 242-249.
42. National Health and Medical Research Council (1999). Familial aspects of cancer: A guide to clinical practice. Canberra, National Health and Medical Research Council.
43. O'Connor, A., Llewellyn-Thomas, H., & Stacey, D. (2005). International Patient Decision Aid Standards Collaboration Background Document. Ottawa, Ottawa Health Research Institute:, pp. 1-54.
44. O'Connor, A., Tugwell, P., Welles, G. A., Elmslie, T., et al. (1998). Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventative hormone replacement therapy. Med Decis Making, 18, 295-303.
45. O'Connor, A. M. (1995). Validation of a decisional conflict scale. Med Decis Making, 15(1), 25-30.
46. O'Connor, A. M. (1999). Decision aids for patients considering options affecting cancer outcomes: Evidence of efficacy and policy implications. J Natl Cancer Inst, 25, 67-80.
47. O'Connor, A. M., Rostom, A., Fiset, V., Tetroe, J., et al. (1999). Decision aids for patients facing health treatment or screening decisions: Systematic review. Br Med J, 731-734.
48. O'Connor, A. M., Stacey, D., Entwistle, V., Llewellyn-Thomas, H., et al. (2006). Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev, 1, 1.
49. Ozanne, E. M., Klemp, J. R., & Esserman, L. J. (2006). Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Breast J, 12(2), 103-113.
50. Peters, N., Domcheck, S. M., Rose, A., Polis, R., et al. (2005). Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer. Genet Test, 9(1), 48-53.
51. Quehenberger, F., Vasen, H. F. A., & Van Houwelingen, H. C. (2005). Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: Correction for ascertainment. J Med Genet, 42(6), 491-496.
52. Rapport, F., Iredale, R., Jones, W., Sivell, S., et al. (2006). Decision aids for familial breast cancer: exploring women's views using focus groups. Health Expectations, 9(3), 232-244.
53. Rebbeck, T., Lynch, H., Neuhausen, S., Narod, S., et al. (2002). Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med, 346(21), 1616-1622.
54. Rebbeck, T. R., Levin, A. M., Eisen, A., Snyder, C., et al. (1999). Breast cancer risk after prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst, 91(17), 1475-1479.
55. Ritvo, P., Robinson, G., Irvine, J., Phil, D., et al. (1999). A longitudinal study of psychological adjustment to familial genetic risk assessment for ovarian cancer. Gynecol Oncol, 74(3), 331-337.
56. Schwartz, M., Benkendorf, J. L., Lerman, C., Isaacs, C., et al. (2001). Impact of educational print materials on knowledge, attitudes and interest in BRCA1/BRCA2 testing among Ashkenazi Jewish women. Cancer, 92(4), 932-940.
57. Schwartz, M., Peshkin, B., Hughs, C., Main, D., et al. (2002). Impact of BRCA1/BRCA2 mutation testing on psychological distress in a clinic-based sample. J Clin Oncol, 20(2), 514-520.
58. Smith, K. R., West, J. A., Croyle, R. T., & Botkin, J. R. (1999). Familial context of genetic testing for cancer susceptibility: Moderating effect of siblings' test result on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol Biomarkers Prev, 8, 385-392.
59. Strate, L. L., & Syngal, S. (2005). Hereditary colorectal cancer syndromes. Cancer Causes Control, 16(3), 201-213.
60. Thewes, B., Meiser, B., Taylor, A., Phillips, K., et al. (2005). The fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol, 23(22), 5155-5165.
61. van Dijk, S., Otten, W., Timmermans, D. R., van Asperen, C. J., et al. (2005). What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genet Med, 7(4), 239-245.
62. van Oostrom, I., Meijers-Heijboer, H., Lodder, L. N., Duivenvoorden, H. J., et al. (2003). Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol, 21(20), 3867-3874.
63. van Roosmalen, M. S., Stalmeier, P. F., Verhoef, L. C., Hoekstra-Weebers, J. E., et al. (2004a). Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet, Part A, 124(4), 346-355.
64. van Roosmalen, M. S., Stalmeier, P. F., Verhoef, L. C., Hoekstra-Weebers, J. E., et al. (2004b). Randomized trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. Br J Cancer, 90(2), 333-342.
65. Wagner, A., van Kessel, I., Kriege, M. G., Tops, C. M., et al. (2005). Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Familial Cancer, 4(4), 295-300.
66. Wagner, T. M. U., Moslinger R., Lanbauer, G., Ahner, R., et al. (2000). Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Br J Cancer, 82(7), 1249-1253.
67. Wang, C., Bowen, D. J., & Kardia, S. L. (2005). Research and Practice Opportunities at the Intersection of Health Education, Health Behavior, and Genomics. Health Educ Behav, 32(5), 686-701.
68. Watson, M., Foster, C., Eeles, R., Eccles, D., et al. (2004). Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer, 91(10), 1787-1794.
69. Weinstein, N. D., Atwood, K., Puleo, E., Fletcher, R., et al. (2004). Colon cancer: risk perceptions and risk communication. J Health Commun, 9(1), 53-65.
70. Wise, P. E., & Mutch, M. G. (2005). Hereditary nonpolyposis colorectal cancer. Semin Colon Rectal Surg, 15(3), 136-146.